Which disorder is described as a systemic thrombohemorrhagic condition with both excessive coagulation and fibrinolytic activation?

Which disorder is described as a systemic thrombohemorrhagic condition with both excessive coagulation and fibrinolytic activation?

• A. DIC (Disseminated Intravascular Coagulation)
• B. Cardiac Output
• C. Absence seizure
• D. Delta Wave

Answer: (A)

DIC describes a systemic thrombohemorrhagic process where widespread activation of coagulation creates microvascular clots throughout the body while the clotting factors and platelets are consumed, leading to a tendency to bleed. The simultaneous activation of fibrinolysis keeps breaking down these clots, so you can see both clotting and bleeding happening together. Triggers like severe infection (sepsis), major trauma, obstetric emergencies, or cancer can set off this runaway coagulation. Lab clues include prolonged PT and aPTT, low platelets, elevated D-dimer, and often low fibrinogen. Clinically, you may notice bleeding from mucosal sites or wounds along with signs of organ dysfunction from microthrombi. Management focuses on treating the underlying cause and providing supportive transfusions (platelets, fresh frozen plasma, cryoprecipitate for low fibrinogen) as needed. In the prehospital/ACP setting, recognize the potential for a systemic coagulopathy, monitor closely, and arrange rapid transport for definitive care. The other options describe unrelated conditions (a cardiac output measure, a type of seizure, an EEG pattern) and do not reflect a systemic coagulation–fibrinolysis disorder.

DIC describes a systemic thrombohemorrhagic process where widespread activation of coagulation creates microvascular clots throughout the body while the clotting factors and platelets are consumed, leading to a tendency to bleed. The simultaneous activation of fibrinolysis keeps breaking down these clots, so you can see both clotting and bleeding happening together. Triggers like severe infection (sepsis), major trauma, obstetric emergencies, or cancer can set off this runaway coagulation. Lab clues include prolonged PT and aPTT, low platelets, elevated D-dimer, and often low fibrinogen. Clinically, you may notice bleeding from mucosal sites or wounds along with signs of organ dysfunction from microthrombi. Management focuses on treating the underlying cause and providing supportive transfusions (platelets, fresh frozen plasma, cryoprecipitate for low fibrinogen) as needed. In the prehospital/ACP setting, recognize the potential for a systemic coagulopathy, monitor closely, and arrange rapid transport for definitive care. The other options describe unrelated conditions (a cardiac output measure, a type of seizure, an EEG pattern) and do not reflect a systemic coagulation–fibrinolysis disorder.